You have 9 free searches left this month | to do more
Showing 1 - 25 of
>10,000 items
Trials Per Page
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
H
Cell Therapy for CD7 Positive T-cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma Using CD7-Specific CAR-T Cells - 2021
Completed
  • T-cell Acute Lymphoblastic Leukemia/Lymphoma
  • CD7 CAR-T
  • Yanda, Hebei, China
    Hebei yanda Ludaopei Hospital
2021-06-23
Jun 23, 2021
F
A Study of TKI Maintenance Therapy Following Allo-HSCT in Newly Diagnosed Ph+ Adult ALL
Recruiting
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma
  • +2 more
  • Xi'an, Shaanxi, China
    First Affiliated Hospital of Xian Jiaotong University
2021-09-29
Sep 29, 2021
i
CD7 CAR-T Cell Treatment of Relapsed/Refractory CD7+ T -Acute Lymphoblastic Leukemia/ Lymphoma
Recruiting
  • Relapsed/Refractory, High Risk Hematologic Malignancies
  • T-ALL/Lymphoma
  • CD7CAR T cells
  • Langfang, Hebei, China
    Hebei Yanda Lu Daopei Hospital
2022-01-16
Jan 16, 2022
S
Blinatumomab in Pediatric B-cell Acute Lymphoblastic Leukemia (ALL) With Minimal Residual Disease (MRD)
Recruiting
  • Pediatric ALL, B Cell
  • Minimal Residual Disease
  • Blinatumomab for Injection
  • Seoul, Korea, Republic of
    Seoul National University Hospital
2022-02-20
Feb 20, 2022
S
NGS-MRD Assessment of Combination Immunotherapies Targeting T-ALL
Recruiting
  • T-Cell Acute Lymphoblastic Leukemia
  • Antigen-specific T cells CAR-T/CTL and DCvac
  • Shenzhen, Guangdong, China
    Shenzhen Geno-immune Medical Institute
2022-03-14
Mar 14, 2022
A
FoxO3a and PU.1 in Acute Lymphoblastic Leukemia
Not yet recruiting
  • Acute Lymphoblastic Leukemia
  • complete blood count
  • (no location specified)
2022-02-15
Feb 15, 2022
N
CD19- and CD22-directed CAR-T Cell Therapy in Patients With Acute Lymphoblastic Leukemia
Not yet recruiting
  • Acute Lymphoblastic Leukemia
  • IMJ995 single agent
  • (no location specified)
2022-02-17
Feb 17, 2022
E
XmAb18968 (CD3-CD38) in Relapsed or Refractory Acute Leukemia and T Cell Lymphoblastic Leukemia
Recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • XmAb18968 - Dose level -1
  • +4 more
  • Milwaukee, Wisconsin
    Froedtert Hospital & the Medical College of Wisconsin
2022-02-15
Feb 15, 2022
G
Venetoclax in Addition to Blinatumomab in Adult Patients With Relapsed/Refractory B Cell Precursor Acute Lymphoblastic Leukemia Relapsed/Refractory B Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL)
Recruiting
  • ALL, Recurrent, Adult
  • Frankfurt (Main), Hessen, Germany
  • +1 more
2022-01-06
Jan 6, 2022
M
Precursor B Cell Acute Lymphoblastic Leukemia (B-ALL) Treated With Autologous T Cells Genetically Targeted to the B Cell Specific Antigen CD19
Active, not recruiting
  • Leukemia
  • Acute Lymphoblastic Leukemia
  • gene-modified T cells targeted
  • New York, New York
    Memorial Sloan Kettering Cancer Center
2022-02-01
Feb 1, 2022
N
Targeted Immunotherapy After Myeloablative TBI-Based Conditioning & AlloHCT in CAYA With High Risk T-Cell ALL & Lymphoma
Not yet recruiting
  • T-cell Acute Lymphoblastic Leukemia
  • T-Cell Acute Lymphoblastic Lymphoma
  • (no location specified)
2021-07-13
Jul 13, 2021
G
Ponatinib Plus Chemotherapy in Acute Lymphoblastic Leukemia Patients
Not yet recruiting
  • Chemotherapy
  • Leukemia, Acute Lymphoblastic
  • (no location specified)
2022-03-23
Mar 23, 2022
F
A Study of Dasatinib Plus Reduced Intensive Consolidation Chemotherapy in Ph+ Adult ALL
Recruiting
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma
  • +2 more
  • dasatinib plus consolidation chemotherapy with vincristine and prednisone
  • dasatinib plus consolidation chemotherapy with high-dose methotrexate and cytarabine
  • Xi'an, Shaanxi, China
    First Affiliated Hospital of Xian Jiaotong University
2021-09-29
Sep 29, 2021
i
Non-gene Edited Anti-CD7 CAR T Cells for Relapsed/Refractory T Cell Malignances
Recruiting
  • T-cell Acute Lymphoblastic Leukemia
  • +2 more
  • CD7 CAR T cells
  • Shenzhen, Guangdong, China
    Peking University Shenzhen Hospital
2021-06-19
Jun 19, 2021
P
InO - A Retrospective Study of UK Patients With Leukaemia - 2021
Completed
Has Results
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma
  • Inotuzumab Ozogamicin
  • Bristol, United Kingdom
  • +3 more
2022-01-27
Jan 27, 2022
B
Donor-Derived CD5 CAR T Cells in Subjects With Relapsed or Refractory T-Cell Acute Lymphoblastic Leukemia
Recruiting
  • T-Cell Acute Lymphoblastic Leukemia
  • CD5 CART
  • Beijing, Beijing, China
    Beijing Boren Hospital
2022-03-16
Mar 16, 2022
M
RD13-01 for Patients With r/r CD7+ T-ALL/T-LBL
Recruiting
  • T Acute Lymphoblastic Leukemia
  • T-lymphoblastic Lymphoma
  • RD13-01 cell infusion
  • Langfang, Hebei, China
    Hebei Yanda Ludaopei Hospital
2020-11-03
Nov 3, 2020
M
A Phase II Study of the Combination of Ponatinib With Mini-hyper CVD Chemotherapy and Venetoclax in Patients With Relapsed or Refractory T-cell Acute Lymphoblastic Leukemia
Not yet recruiting
  • Acute Lymphoblastic Leukemia
  • Leukemia
  • Houston, Texas
    MD Anderson Cancer Center
2022-03-07
Mar 7, 2022
A
Blinatumomab in High-risk B-cell Precursor Acute Lymphoblastic Leukemia
Active, not recruiting
  • Acute Lymphoblastic Leukemia, Adult B-Cell
  • Blinatumomab Injection
  • Paris, France
    Hopital saint Louis
2021-04-30
Apr 30, 2021
M
Blinatumomab Maintenance Following Allogeneic Hematopoietic Cell Transplantation for Patients With Acute Lymphoblastic Leukemia - 2022
Completed
  • Acute Lymphoblastic Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
2022-02-09
Feb 9, 2022
9
CD19 Targeted UCAR-T for CD19+ Refractory/Relapsed B-ALL/NHL
Recruiting
  • B-cell Acute Lymphoblastic Leukemia and B-cell Lymphoma
  • anti-CD19 UCAR-T injection
  • Kunming, Yunnan, China
    920th Hospital of Joint Logistics Support Force of People's Libe
2021-10-25
Oct 25, 2021
S
Anti-CD7 CAR-T Cell Therapy for Relapse and Refractory CD7 Positive T Cell Malignancies
Not yet recruiting
  • T Lymphoblastic Leukemia/Lymphoma
  • +4 more
  • anti-CD7 CAR-T cells
  • (no location specified)
2022-03-18
Mar 18, 2022
S
Anti-CD19/CD22 Bispecific CAR-T Cell Therapy for MRD Positive ALL
Recruiting
  • MRD-positive
  • Acute Lymphoblastic Leukemia
  • anti-CD19/CD22 CAR-T cells
  • +2 more
  • Shanghai, Shanghai, China
    Shanghai General Hospital
2021-09-23
Sep 23, 2021
U
Pharmacogenomics of Asparaginase Induced Hepatotoxicity
Recruiting
  • Acute Lymphoblastic Leukemia
  • Biospecimen Collection
  • Los Angeles, California
    USC / Norris Comprehensive Cancer Center
2021-11-16
Nov 16, 2021
i
Anti-CD5 CAR T Cells for Relapsed/Refractory T Cell Malignancies
Recruiting
  • T-cell Acute Lymphoblastic Leukemia
  • T-cell Non-Hodgkin Lymphoma
  • anti-CD5 CAR T cells
  • Shenzhen, Guangdong, China
    Peking University Shenzhen Hospital
2021-02-27
Feb 27, 2021